Microglial Responses to Alzheimer's Disease Pathology: Insights From "Omics" Studies

Overview

Journal Glia

Specialty Neurology

Date 2025 Jan 6

PMID 39760224

Authors

Aquene N Reid

Suman Jayadev

Katherine E Prater

Affiliations

Soon will be listed here.

Abstract

Human genetics studies lent firm evidence that microglia are key to Alzheimer's disease (AD) pathogenesis over a decade ago following the identification of AD-associated genes that are expressed in a microglia-specific manner. However, while alterations in microglial morphology and gene expression are observed in human postmortem brain tissue, the mechanisms by which microglia drive and contribute to AD pathology remain ill-defined. Numerous mouse models have been developed to facilitate the disambiguation of the biological mechanisms underlying AD, incorporating amyloidosis, phosphorylated tau, or both. Over time, the use of multiple technologies including bulk tissue and single cell transcriptomics, epigenomics, spatial transcriptomics, proteomics, lipidomics, and metabolomics have shed light on the heterogeneity of microglial phenotypes and molecular patterns altered in AD mouse models. Each of these 'omics technologies provide unique information and biological insight. Here, we review the literature on the approaches and findings of these methods and provide a synthesis of the knowledge generated by applying these technologies to mouse models of AD.

References

Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland T . A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease. Cell. 2017; 169(7):1276-1290.e17. DOI: 10.1016/j.cell.2017.05.018. View

Rayess H, Wang M, Srivatsan E . Cellular senescence and tumor suppressor gene p16. Int J Cancer. 2011; 130(8):1715-25. PMC: 3288293. DOI: 10.1002/ijc.27316. View

Bellenguez C, Kucukali F, Jansen I, Kleineidam L, Moreno-Grau S, Amin N . New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat Genet. 2022; 54(4):412-436. PMC: 9005347. DOI: 10.1038/s41588-022-01024-z. View

Sierra A, Paolicelli R, Kettenmann H . Cien Años de Microglía: Milestones in a Century of Microglial Research. Trends Neurosci. 2019; 42(11):778-792. DOI: 10.1016/j.tins.2019.09.004. View

Westergard L, Christensen H, Harris D . The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim Biophys Acta. 2007; 1772(6):629-44. PMC: 1986710. DOI: 10.1016/j.bbadis.2007.02.011. View

Yagi T, Giallourakis C, Mohanty S, Scheidig C, Shen J, Zheng H . Defective signal transduction in B lymphocytes lacking presenilin proteins. Proc Natl Acad Sci U S A. 2008; 105(3):979-84. PMC: 2242696. DOI: 10.1073/pnas.0707755105. View

Naj A, Jun G, Beecham G, Wang L, Vardarajan B, Buros J . Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011; 43(5):436-41. PMC: 3090745. DOI: 10.1038/ng.801. View

Jin C, Shao Y, Zhang X, Xiang J, Zhang R, Sun Z . A Unique Type of Highly-Activated Microglia Evoking Brain Inflammation via Mif/Cd74 Signaling Axis in Aged Mice. Aging Dis. 2021; 12(8):2125-2139. PMC: 8612608. DOI: 10.14336/AD.2021.0520. View

Ferretti M, Iulita M, Cavedo E, Chiesa P, Dimech A, Chadha A . Sex differences in Alzheimer disease - the gateway to precision medicine. Nat Rev Neurol. 2018; 14(8):457-469. DOI: 10.1038/s41582-018-0032-9. View

10.

Sierksma A, Lu A, Mancuso R, Fattorelli N, Thrupp N, Salta E . Novel Alzheimer risk genes determine the microglia response to amyloid-β but not to TAU pathology. EMBO Mol Med. 2020; 12(3):e10606. PMC: 7059012. DOI: 10.15252/emmm.201910606. View

11.

Emre C, Do K, Jun B, Hjorth E, Alcalde S, Kautzmann M . Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer's disease. Acta Neuropathol Commun. 2021; 9(1):116. PMC: 8244172. DOI: 10.1186/s40478-021-01216-4. View

12.

Wang J, Ho W, Lim K, Feng J, Tucker-Kellogg G, Nave K . Cell-autonomous requirement of TDP-43, an ALS/FTD signature protein, for oligodendrocyte survival and myelination. Proc Natl Acad Sci U S A. 2018; 115(46):E10941-E10950. PMC: 6243235. DOI: 10.1073/pnas.1809821115. View

13.

Streit W, Khoshbouei H, Bechmann I . Dystrophic microglia in late-onset Alzheimer's disease. Glia. 2020; 68(4):845-854. DOI: 10.1002/glia.23782. View

14.

Cantoni C, Bollman B, Licastro D, Xie M, Mikesell R, Schmidt R . TREM2 regulates microglial cell activation in response to demyelination in vivo. Acta Neuropathol. 2015; 129(3):429-47. PMC: 4667728. DOI: 10.1007/s00401-015-1388-1. View

15.

Flowers A, Bell-Temin H, Jalloh A, Stevens Jr S, Bickford P . Proteomic anaysis of aged microglia: shifts in transcription, bioenergetics, and nutrient response. J Neuroinflammation. 2017; 14(1):96. PMC: 5415769. DOI: 10.1186/s12974-017-0840-7. View

16.

Greve H, Dunbar A, Lombo C, Ahmed C, Thang M, Messenger E . The bidirectional lung brain-axis of amyloid-β pathology: ozone dysregulates the peri-plaque microenvironment. Brain. 2022; 146(3):991-1005. PMC: 10169526. DOI: 10.1093/brain/awac113. View

17.

Goate A, Chartier-Harlin M, Mullan M, Brown J, Crawford F, Fidani L . Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991; 349(6311):704-6. DOI: 10.1038/349704a0. View

18.

Braak H, Braak E . Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991; 82(4):239-59. DOI: 10.1007/BF00308809. View

19.

Ford M, Burton L, Morris R, Hall S . Selective expression of prion protein in peripheral tissues of the adult mouse. Neuroscience. 2002; 113(1):177-92. DOI: 10.1016/s0306-4522(02)00155-0. View

20.

Hajdarovic K, Yu D, Hassell L, Evans S, Packer S, Neretti N . Single-cell analysis of the aging female mouse hypothalamus. Nat Aging. 2022; 2(7):662-678. PMC: 9592060. DOI: 10.1038/s43587-022-00246-4. View